Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenues
Operating Expenses:
Personnel costs	286,327	406,407
Research and development expenses, related party	102,180	98,983
Professional fees	330,380	474,408
General and administrative expenses	46,957	54,111
Total operating expenses	765,844	1,033,909
Loss from continuing operations before income taxes	(765,844)	(1,033,909)
Income taxes
Loss from continuing operations	(765,844)	(1,033,909)
Loss from discontinued operations		(375,787)
Net Loss	(765,844)	(1,409,696)
Deemed dividend		(160,479)
Net Loss available to common shareholders	$ (765,844)	$ (1,570,175)
Basic and diluted net loss per common share
Continuing operations	$ (0.10)	$ (0.10)
Discontinued operations		(0.03)
Earnings per share, basic and diluted	$ (0.10)	$ (0.13)
Basic and diluted weighted average common shares outstanding	17,483,283	11,403,333